Meghan Claire Ramsey, MD
Critical Care (Intensivists) · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ramsey’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A109107 · Current
Licensed to practise in California · since 2009 · expires 2027-06-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$66,946
Medicare paid this office $66,946 for 341 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 116 | $45,489 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $9,608 | $106 |
| Critical care, each additional 30 minutes | 13 | $2,986 | $93 |
| Return visit (30+ min) | 11 | $1,009 | $78 |
| Test to examine how well the lungs exchange gases | 95 | $697 | $7 |
See all 8 services
| Critical care, first 30-74 minutes | 116 | $45,489 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $9,608 | $106 |
| Critical care, each additional 30 minutes | 13 | $2,986 | $93 |
| Return visit (30+ min) | 11 | $1,009 | $78 |
| Test to examine how well the lungs exchange gases | 95 | $697 | $7 |
| Test to measure expiratory airflow and volume | 84 | $559 | $6 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 53 | $435 | $8 |
| Test to determine lung volumes using sensors | 34 | $318 | $9 |
Who their Medicare patients are
341 Original Medicare patients in 2024. Average age 74 · Under 65 13% · 85 and older 14% · Women 50% · Also on Medicaid 30% · Health risk score 2.71. Above the middle of the specialty; the typical critical care (intensivists) clinician is at 2.58.
Conditions among them: High blood pressure 75% · Coronary heart disease 46% · Heart failure 44% · Atrial fibrillation 42% · Diabetes 41% · Chronic kidney disease 40% · COPD 40% · Depression 28% · Cancer 26% · Stroke 22% · Dementia 19%.
The office billed $618,114, Medicare allowed $85,460 and paid $66,946; for 717 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 341 | 717 | 74 | 2.71 | $618,114 | $66,946 |
| 2023 | 242 | 570 | 73 | 2.69 | $569,854 | $64,114 |
| 2022 | 332 | 771 | 73 | 2.06 | $655,433 | $76,130 |
| 2021 | 335 | 734 | 74 | 2.09 | $697,792 | $82,119 |
| 2020 | 328 | 776 | 74 | 2.53 | $671,388 | $91,012 |
| 2019 | 479 | 1,019 | 73 | 2.26 | $337,167 | $58,165 |
| 2018 | 472 | 1,166 | 74 | 2.48 | $495,740 | $100,000 |
| 2017 | 434 | 1,109 | 72 | 2.30 | $552,697 | $82,013 |
| 2016 | 439 | 1,086 | 73 | 2.20 | $485,784 | $83,138 |
| 2015 | 172 | 409 | 73 | 2.03 | $266,768 | $31,904 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Critical care, first 30-74 minutes | 97 | $49,632 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $3,636 | $107 |
| Return visit (30+ min) | 17 | $1,791 | $90 |
| Return visit (30+ min) | 11 | $1,094 | $78 |
| Test to examine how well the lungs exchange gases | 64 | $517 | $8 |
| Test to measure expiratory airflow and volume | 47 | $352 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 35 | $328 | $9 |
| Test to determine lung volumes using sensors | 27 | $296 | $11 |
2022: 9 services
| Critical care, first 30-74 minutes | 117 | $58,462 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $2,791 | $93 |
| Return visit (30+ min) | 17 | $2,253 | $90 |
| Return visit (30+ min) | 23 | $2,219 | $72 |
| New patient visit (45+ min) | 15 | $1,854 | $124 |
| Test to examine how well the lungs exchange gases | 102 | $750 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 66 | $558 | $8 |
| Test to determine lung volumes using sensors | 49 | $475 | $10 |
| Test to measure expiratory airflow and volume | 71 | $459 | $6 |
2021: 9 services
| Critical care, first 30-74 minutes | 120 | $54,868 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $5,617 | $94 |
| Return visit (30+ min) | 27 | $3,473 | $94 |
| Return visit (30+ min) | 26 | $2,677 | $84 |
| New patient visit (45+ min) | 18 | $2,307 | $128 |
| Test to examine how well the lungs exchange gases | 64 | $525 | $8 |
| Test to measure expiratory airflow and volume | 60 | $463 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 35 | $328 | $9 |
| Test to determine lung volumes using sensors | 28 | $305 | $11 |
2020: 10 services
| Critical care, first 30-74 minutes | 106 | $55,779 | $201 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $6,070 | $95 |
| Return visit (30+ min) | 45 | $4,262 | $66 |
| New patient visit (45+ min) | 24 | $2,664 | $111 |
| Return visit (30+ min) | 27 | $2,390 | $65 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 14 | $895 | $64 |
| Test to examine how well the lungs exchange gases | 39 | $343 | $9 |
| Test to measure expiratory airflow and volume | 37 | $302 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 19 | $234 | $12 |
| Test to determine lung volumes using sensors | 15 | $174 | $12 |
2019: 17 services
| Critical care, first 30-74 minutes | 24 | $8,868 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $6,409 | $94 |
| Return visit (30+ min) | 47 | $4,844 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,405 | $184 |
| New patient visit (45+ min) | 33 | $3,755 | $114 |
| Return visit (30+ min) | 42 | $3,412 | $66 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 12 | $2,324 | $194 |
| New patient visit (45+ min) | 16 | $1,866 | $117 |
| Test to examine how well the lungs exchange gases | 160 | $1,424 | $8 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,361 | $124 |
| Hospital discharge day management, 30 minutes or less | 18 | $1,216 | $68 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 95 | $1,188 | $12 |
| Test to measure expiratory airflow and volume | 132 | $1,103 | $8 |
| Aspiration of fluid from chest cavity | 13 | $1,064 | $76 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 21 | $1,017 | $48 |
| Test to determine lung volumes using sensors | 71 | $835 | $11 |
| Short return visit (20+ min) | 12 | $604 | $46 |
2018: 23 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 93 | $19,425 | $92 |
| Critical care, first 30-74 minutes | 24 | $9,072 | $189 |
| Return visit (30+ min) | 71 | $8,406 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $8,225 | $179 |
| Aspiration of fluid from chest cavity using imaging guidance | 17 | $5,935 | $99 |
| New patient visit (45+ min) | 47 | $5,303 | $113 |
| Return visit (30+ min) | 56 | $4,730 | $61 |
| Aspiration of fluid from chest cavity using imaging guidance | 22 | $3,483 | $100 |
| New patient visit (45+ min) | 30 | $3,427 | $114 |
| Hospital discharge day management, 30 minutes or less | 51 | $3,293 | $65 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 17 | $3,149 | $185 |
| Initial hospital observation care per day, typically 70 minutes | 13 | $2,174 | $167 |
| Long return visit (40+ min) | 17 | $1,895 | $100 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,589 | $122 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 28 | $1,471 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,436 | $65 |
| Long return visit (40+ min) | 15 | $1,353 | $90 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $985 | $90 |
| Short return visit (20+ min) | 13 | $599 | $46 |
| Test to examine how well the lungs exchange gases | 54 | $443 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 26 | $307 | $12 |
| Test to measure expiratory airflow and volume | 36 | $273 | $8 |
| Test to determine lung volumes using sensors | 17 | $189 | $11 |
2017: 27 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $9,249 | $91 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 42 | $8,141 | $189 |
| Return visit (30+ min) | 60 | $7,304 | $64 |
| New patient visit (45+ min) | 52 | $5,603 | $108 |
| New patient visit (45+ min) | 47 | $5,184 | $110 |
| Return visit (30+ min) | 53 | $5,063 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,560 | $175 |
| Aspiration of fluid from chest cavity using imaging guidance | 15 | $4,234 | $96 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | 13 | $2,787 | $214 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,723 | $118 |
| Aspiration of fluid from chest cavity using imaging guidance | 17 | $2,413 | $97 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 50 | $2,397 | $46 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 20 | $2,076 | $104 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 14 | $1,846 | $132 |
| New patient visit (60+ min) | 11 | $1,604 | $146 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 18 | $1,451 | $81 |
| Hospital discharge day management, 30 minutes or less | 22 | $1,414 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,068 | $63 |
| Long return visit (40+ min) | 11 | $1,063 | $97 |
| Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | 14 | $779 | $56 |
| Test to examine how well the lungs exchange gases | 85 | $645 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 51 | $526 | $10 |
| Test to determine lung volumes using sensors | 38 | $377 | $10 |
| Test to measure expiratory airflow and volume | 49 | $353 | $7 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $127 | $11 |
| Test to measure expiratory airflow and volume | 14 | $81 | $6 |
| Exam of lung airways using an endoscope | 16 | $41 | $3 |
2016: 21 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $14,259 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $9,914 | $180 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 32 | $6,607 | $206 |
| New patient visit (45+ min) | 44 | $4,975 | $113 |
| New patient visit (45+ min) | 41 | $4,729 | $115 |
| Return visit (30+ min) | 37 | $4,553 | $70 |
| Return visit (30+ min) | 35 | $3,572 | $70 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,452 | $119 |
| Hospital discharge day management, 30 minutes or less | 47 | $3,221 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $2,958 | $64 |
| Aspiration of fluid from chest cavity using imaging guidance | 11 | $2,428 | $101 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 40 | $2,414 | $60 |
| New patient visit (60+ min) | 12 | $1,797 | $150 |
| Aspiration of fluid from chest cavity using imaging guidance | 12 | $1,315 | $101 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 13 | $1,121 | $86 |
| Test to examine how well the lungs exchange gases | 102 | $843 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 49 | $577 | $12 |
| Test to measure expiratory airflow and volume | 71 | $546 | $8 |
| Test to determine lung volumes using sensors | 33 | $366 | $11 |
| Exam of lung airways using an endoscope | 22 | $186 | $8 |
| Test to measure expiratory airflow and volume | 22 | $159 | $7 |
2015: 16 services
| New patient visit (45+ min) | 42 | $4,862 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $3,639 | $93 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 19 | $3,607 | $180 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,447 | $181 |
| Return visit (30+ min) | 20 | $1,687 | $70 |
| Ultrasound of lung airways using an endoscope | 21 | $1,331 | $61 |
| Hospital discharge day management, 30 minutes or less | 20 | $1,329 | $66 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,259 | $90 |
| Aspiration of fluid from chest cavity using imaging guidance | 12 | $1,224 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,168 | $65 |
| Needle biopsy of lobe of lung using an endoscope, each additional lobe | 13 | $740 | $57 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 15 | $703 | $47 |
| Short return visit (20+ min) | 11 | $547 | $46 |
| Test to examine how well the lungs exchange gases | 30 | $246 | $8 |
| Test to measure expiratory airflow and volume | 27 | $205 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 17 | $201 | $12 |
Medicaid work
$14,036 in 2024
Medicaid paid $14,036 for 141 billed services this clinician did in 2024, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 95 | $13,730 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 16 | $156 |
| Diffusing capacity | 30 | $150 |
| 2024 | 141 | 3 | 19 | $14,036 |
| 2023 | 125 | 5 | 18 | $7,547 |
| 2022 | 95 | 3 | 16 | $4,550 |
| 2021 | 170 | 1 | 16 | $17,915 |
| 2020 | 226 | 1 | 20 | $20,150 |
| 2019 | 111 | 4 | 23 | $1,016 |
| 2018 | 43 | 3 | 18 | $347 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 54 | $7,151 |
| Diffusing capacity | 32 | $158 |
| EVALUATION OF WHEEZING | 15 | $90 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 12 | $83 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 12 | $66 |
2022
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 68 | $4,319 |
| EVALUATION OF WHEEZING | 14 | $169 |
| Diffusing capacity | 13 | $62 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 170 | $17,915 |
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 226 | $20,150 |
2019
| EVALUATION OF WHEEZING | 31 | $497 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 28 | $223 |
| Diffusing capacity | 40 | $215 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 12 | $81 |
2018
| EVALUATION OF WHEEZING | 12 | $231 |
| Diffusing capacity | 18 | $79 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 13 | $37 |
Drugs they prescribed that Part D paid
$24,852
Pharmacies billed $24,852 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 76) in 2024. At or below the middle of the specialty; the typical critical care (intensivists) clinician is at 0%.
21 generic and 55 brand-name prescriptions · $24,852 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Spiriva Handihaler | 21 | $10,516 | $501 |
| Fluticasone-Salmeterol | 21 | $1,720 | $82 |
| Albuterol Sulfate Hfa | 12 | $438 | $37 |
Year by year
| 2024 | 76 | 14 | 0% (0) | 72% | $24,852 |
| 2023 | 66 | 12 | 0% (0) | 82% | $30,629 |
| 2022 | 74 | 22 | 0% (0) | 68% | $25,985 |
| 2021 | 139 | 25 | 0% (0) | 68% | $38,334 |
| 2020 | 235 | 46 | 0% (0) | 69% | $62,653 |
| 2019 | 213 | 66 | 0% (0) | 56% | $45,192 |
| 2018 | 367 | 95 | None | 52% | $92,364 |
| 2017 | 260 | 65 | None | 48% | $51,422 |
| 2016 | 188 | 65 | None | None | $19,133 |
| 2015 | 67 | 25 | 0% (0) | 40% | $17,746 |
| 2014 | 25 | None | 0% (0) | 64% | $3,524 |
| 2013 | 25 | None | 0% (0) | 44% | $4,378 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Advair Diskus | 16 | $11,790 | $737 |
| Spiriva Handihaler | 11 | $6,255 | $569 |
| Albuterol Sulfate Hfa | 16 | $784 | $49 |
2022: 1 drug
| Advair Diskus | 11 | $11,819 | $1,074 |
2021: 2 drugs
| Albuterol Sulfate Hfa | 22 | $995 | $45 |
| Prednisone | 13 | $124 | $10 |
2020: 8 drugs
| Spiriva | 22 | $9,932 | $451 |
| Incruse Ellipta | 11 | $6,783 | $617 |
| Flovent Hfa | 13 | $4,722 | $363 |
| Symbicort | 12 | $4,578 | $382 |
| Breo Ellipta | 12 | $4,485 | $374 |
| Albuterol Sulfate Hfa | 32 | $1,530 | $48 |
| Proair Hfa | 11 | $728 | $66 |
| Prednisone | 18 | $113 | $6 |
2019: 5 drugs
| Incruse Ellipta | 12 | $6,745 | $562 |
| Spiriva | 13 | $5,802 | $446 |
| Flovent Hfa | 13 | $5,518 | $424 |
| Ventolin Hfa | 23 | $1,320 | $57 |
| Fluticasone Propionate | 15 | $212 | $14 |
2018: 8 drugs
| Advair Diskus | 44 | $19,509 | $443 |
| Spiriva | 21 | $10,128 | $482 |
| Symbicort | 15 | $5,313 | $354 |
| Incruse Ellipta | 13 | $4,268 | $328 |
| Ventolin Hfa | 31 | $1,865 | $60 |
| Fluticasone Propionate | 18 | $201 | $11 |
| Prednisone | 19 | $104 | $5 |
| Pantoprazole | 13 | $63 | $5 |
2017: 6 drugs
| Advair Diskus | 32 | $13,928 | $435 |
| Incruse Ellipta | 13 | $4,277 | $329 |
| Ventolin Hfa | 28 | $1,484 | $53 |
| Prednisone | 23 | $112 | $5 |
| Pantoprazole | 13 | $85 | $7 |
| Omeprazole | 14 | $51 | $4 |
2016: 3 drugs
| Ventolin Hfa | 11 | $681 | $62 |
| Prednisone | 15 | $133 | $9 |
| Omeprazole | 11 | $70 | $6 |
2014: 1 drug
| Spiriva | 11 | $3,136 | $285 |
Money from drug and device companies
$21 in 2021
| 2021 | 1 | 1 | None | $21 |
| 2019 | 2 | 3 | $1,348 | $1,393 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sunovion Pharmaceuticals | Gemtesa | $21 | 1 payment
|
See the published payment
| Sunovion Pharmaceuticals | Meals · 2021-06-08 | Gemtesa | $21 |
See earlier years (2019)
2019: $1,393
| AstraZeneca Pharmaceuticals LP | Imfinzi | $1,348 | 2 payments
|
| Ethicon | Monarch | $45 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 94.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1235386178
- Licence
- CA A109107California A109107: Current · expires 2027-06-30
- Trained
- Stanford University School of Medicine, 2008
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A869820
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Internal medicine (207R00000X); Federal specialty code 207RC0200X (207RC0200X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2008-08-21
- NPI last updated
- 2023-10-31
- NPI record certified
- 2023-10-31
This is when the NPI record was last certified, not a medical board exam.